A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

Again, the total cost was mainly composed of indirect costs. In Sweden, the economic burden of MS was evaluated by a cost-of-illness study using a top-down approach of costing. The annual ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study ...

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

also known as relapsing-remitting MS (RRMS). According to the MS Society, in RRMS people have attacks of new and old symptoms, i.e. a relapse. RRMS is the most common type of multiple sclerosis ...